Literature DB >> 8088283

Detection of coronary artery disease by dynamic planar and single photon emission tomographic imaging with technetium-99m teboroxime.

H Yamagami1, Y Ishida, T Morozumi, T Kozuka, T Nishimura.   

Abstract

To test the clinical significance of technetium-99m teboroxime regional myocardial clearance in the detection of coronary artery disease, 25 patients underwent dynamic planar or single-photon emission tomographic (SPET) myocardial imaging with 99mTc-teboroxime after exercise and again 2 h later at rest. All patients underwent both thallium-201 exercise and redistribution SPET and coronary arteriography. The early phases of exercise 99mTc-teboroxime myocardial clearance determined by dynamic planar imaging showed a significant difference between normal and post-stenotic myocardial regions (clearance rate constant k: 0.047 +/- 0.005 min-1 versus 0.034 +/- 0.003 min-1, P < 0.001). Reflecting this "differential clearance" between myocardial regions, an early redistribution-like phenomenon was observed in a significant number of myocardial segments by comparing serially acquired post-exercise 99mTc-teboroxime SPET images. These results indicated that the analysis of 99mTc-teboroxime myocardial clearance was of potential use in the detection of coronary artery disease, yielding additional information to that provided by the tracer distribution analysis. Although the early redistribution-like phenomenon of 99mTc-teboroxime could be the source of underestimation of ischaemia if acquisition of the initial post-exercise image were delayed, it could also prove useful in the early differentiation of ischaemia from scar because when the phenomenon was observed in delayed post-exercise images, the rest study could be omitted under some circumstances.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088283     DOI: 10.1007/bf00182303

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow.

Authors:  R E Stewart; M Schwaiger; G D Hutchins; P C Chiao; K P Gallagher; N Nguyen; N A Petry; W L Rogers
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

2.  Artifacts in camera based single photon emission tomography due to time activity variation.

Authors:  B D Bok; A N Bice; M Clausen; D F Wong; H N Wagner
Journal:  Eur J Nucl Med       Date:  1987

Review 3.  Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.

Authors:  L L Johnson; D W Seldin
Journal:  Am J Cardiol       Date:  1990-10-16       Impact factor: 2.778

4.  Diagnostic value of a new myocardial perfusion agent, teboroxime (SO 30,217), utilizing a rapid planar imaging protocol: preliminary results.

Authors:  R C Hendel; B McSherry; M Karimeddini; J A Leppo
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

5.  A neutral technetium-99m complex for myocardial imaging.

Authors:  R K Narra; A D Nunn; B L Kuczynski; T Feld; P Wedeking; W C Eckelman
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

6.  Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.

Authors:  W L Rumsey; K C Rosenspire; A D Nunn
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

7.  Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.

Authors:  R Taillefer; R Lambert; R Essiambre; D C Phaneuf; J Léveillé
Journal:  J Nucl Med       Date:  1992-06       Impact factor: 10.057

8.  Early myocardial clearance kinetics of technetium-99m-teboroxime differentiate normal and flow-restricted canine myocardium at rest.

Authors:  G Johnson; D K Glover; C B Hebert; R D Okada
Journal:  J Nucl Med       Date:  1993-04       Impact factor: 10.057

9.  Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole.

Authors:  Q S Li; G Solot; T L Frank; H N Wagner; L C Becker
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

10.  Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress.

Authors:  R E Stewart; B Heyl; R A O'Rourke; R Blumhardt; D D Miller
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

View more
  2 in total

1.  Technetium 99m-labeled teboroxime: death in utero, infanticide, or failure to thrive?

Authors:  R J Burns
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

2.  Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium.

Authors:  David R Okada; Gerald Johnson; Robert D Okada
Journal:  EJNMMI Res       Date:  2014-08-01       Impact factor: 3.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.